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BAH domain-containing protein 1 (BAHD1) is involved in heterochromatin formation and
gene repression in human cells. BAHD1 also localizes to the inactive X chromosome
(Xi), but the functional significance of this targeting is unknown. So far, research on
this protein has been hampered by its low endogenous abundance and its role in
epigenetic regulation remains poorly explored. In this work, we used whole-genome
bisulfite sequencing (BS-seq) to compare the DNA methylation profile of HEK293 cells
expressing low levels of BAHD1 (HEK-CT) to that of isogenic cells stably overexpressing
BAHD1 (HEK-BAHD1). We show that increasing BAHD1 levels induces de novo DNA
methylation on autosomes and a marked hypomethylation on the X chromosome (chrX).
We identified 91,358 regions that have different methylation patterns in HEK-BAHD1
compared to HEK-CT cells (termed “BAHD1-DMRs”), of which 83,850 mapped on
autosomes and 7508 on the X chromosome (chrX). Autosomal BAHD1-DMRs were
predominantly hypermethylated and located to satellites, interspersed repeats, and
intergenic regions. In contrast, BAHD1-DMRs on chrX were mainly hypomethylated and
located to gene bodies and enhancers. We further found that BAHD1-DMRs display
a higher-order organization by being clustered within large chromosomal domains.
Half of these “BAHD1-Associated differentially methylated Domains” (BADs) overlapped
with lamina-associated domains (LADs). Based on these results, we propose that
BAHD1-mediated heterochromatin formation is linked to DNA methylation and may play
a role in the spatial architecture of the genome.
Keywords: cytosine methylation, DNA methylation, whole genome bisulfite sequencing, heterochromatin,
epigenetics, LAD, Xi
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INTRODUCTION
DNA methylation is a heritable epigenetic mark that has critical
roles in the regulation of genome structure and transcription
in eukaryotes (for reviews see Suzuki and Bird, 2008; Laird,
2010). This modification, catalyzed by DNA methyltransferases
(DNMTs), is essential for embryonic development and a number
of key processes, such as X chromosome inactivation, genomic
imprinting, chromosome stability, and silencing of repetitive
elements (Li et al., 1993; Jones and Laird, 1999; Baylin et al., 2001;
Geiman and Muegge, 2010). Consistent with these important
roles, changes in DNA methylation are associated with several
human diseases (Robertson, 2005).
In somatic mammalian cells, DNAmethylation mainly occurs
at CpG dinucleotides, with ∼70% of CpG being methylated
(mCpG; Lister et al., 2009). This modification is dynamically
regulated in a developmental context across multiple cell
types (Ziller et al., 2013) and is commonly associated with
gene silencing, especially within CpG islands (CGIs). CGIs
in promoters are predominantly unmethylated and can be
methylated in a tissue-specific manner (Straussman et al.,
2009; Deaton and Bird, 2011). CGI methylation contributes for
instance to the mechanism of X chromosome inactivation (Sharp
et al., 2011), which results in one inactive X chromosome (Xi)
and one active X chromosome (Xa) in mammalian female cells
(Nora and Heard, 2010; Pollex and Heard, 2012). Methylation
of CGI promoters on Xi, in contrast to Xa, correlates with
silencing of ∼85% of all Xi genes (Carrel and Willard, 2005;
Zhang et al., 2013). However, several studies indicate that DNA
methylation is not only functionally linked to gene repression
(Suzuki and Bird, 2008; Ndlovu et al., 2011). For instance,
a positive correlation between active transcription and gene
body methylation has been detected on the Xa and evidence
suggest that X-linked gene bodies are less methylated on Xi
than on Xa (Viegas-Pequignot et al., 1988; Prantera and Ferraro,
1990; Weber et al., 2005; Hellman and Chess, 2007). A link
between active transcription and gene body methylation has also
been detected at highly expressed genes on autosomes (Aran
et al., 2011). Conversely, in cancer cells, formation of repressive
domains coincides with global hypomethylation (Hon et al.,
2012).
Mechanisms controlling which DNA sequences become
methylated involve recruitment of DNMTs at specific loci,
though the driving mechanism is not well understood. There
is a complex interplay between DNA methylation and histone
modifications. This relationship can be partially mediated by
interactions of DNMTs with histone lysine methyltransferases
(KMT, such as SETDB1, SUV39-H1, and G9a) and by action
of mCpG-binding proteins, such as MECP2 and MBDs, that
are capable of recruiting histone deacetylases (HDACs) to
the methylated region (for reviews see Bernstein et al., 2007;
Cedar and Bergman, 2009; Buck-Koehntop and Defossez, 2013).
However, how this scenario unfolds at specific genome loci
according to time, cell type and stimuli, is not well characterized.
Hence, it is crucial to identify components of chromatin-
remodeling complexes that bridge DNA methylation, histone
modifications and transcription factors.
One such component could be BAHD1, a vertebrate-specific
protein that we previously identified as a repressor involved
in chromatin compaction (Bierne et al., 2009). Overexpression
of BAHD1 in human cells is sufficient to stimulate de novo
formation of heterochromatic foci that lack acetylated histone
H4. Also, exogenous BAHD1 localizes to the heterochromatic
Xi in female cell lines. This heterochromatin factor co-purifies
with HDAC1/2, HP1 (α, β, γ), and KAP1/TRIM28 (Lebreton
et al., 2011) and interacts with the methyl-CpG-binding protein
MBD1 and the KMTs SETDB1 (Bierne et al., 2009) and
SUV39-H1 (Weimann et al., 2013) suggesting that it belongs
to a multiprotein chromatin-repressive complex (“the BAHD1
complex”; Bierne et al., 2012). Several BAHD1-associated
partners are known to interact with DNMT3A (Fuks et al., 2001,
2003; Lehnertz et al., 2003; Li et al., 2006) and KAP1 plays a role
in DNAmethylation (Quenneville et al., 2011). Collectively, these
findings suggest an attractive hypothesis wherein BAHD1 plays a
role in the relationship betweenDNAmethylation and chromatin
compaction in higher eukaryotes. However, research on this
protein has been hampered by its absence or low abundance in
mammalian tissues, making it difficult to study its effect on the
epigenome.
In this study, we searched for a connection between BAHD1
and DNA methylation by using, as an experimental model,
Human Embryonic Kidney 293 (HEK293) cells stably expressing
BAHD1. In the widely used HEK293 line, our previous
studies showed that BAHD1-associated heterochromatin and
multiprotein complexes are formed when BAHD1 expression
increases (Bierne et al., 2009; Lebreton et al., 2011). Using
whole genome bisulfite sequencing (BS-seq; Lister et al., 2009),
we generated methylomes at single-nucleotide resolution of
HEK293 cells with endogenous or stable overexpression of
BAHD1. Comparison of the methylation profiles of these
two lines suggests that BAHD1 contributes to the differential
patterning of DNA methylation, both at local (kb) and large
(Mb) genome scales, with distinct effects on autosomes and on
the X chromosome (chrX). In addition, gene expression data
suggest that BAHD1-associated differential methylation could be
associated with transcriptional repression.
MATERIALS AND METHODS
Cell Lines, Plasmids, Antibodies, and
Immunostaining
The stable cell line with constitutive BAHD1 expression (HEK-
BAHD1) and its isogenic control (HEK-CT) are described in the
Supplementary Material. The HPT-BAHD1 inducible cell line
and isogenic HPT-HEK293 control are described in Lebreton
et al. (2011). Cells were grown at 37◦C in a humidified 10%
CO2 incubator, in Dulbecco’s modified Eagle’s medium with
GlutaMAX TM (Gibco) supplemented with 10% FBS (Gibco)
and Hygromycin (HygroGold, Invivogen 200µg/ml). To induce
BAHD1 expression in HPT-BAHD1 cells, tetracycline was added
to cell culturemedia (11µg/ml) 30 h before cell recovery. Plasmid
pYFP-BAHD1, which was used for transient overexpression of
BAHD1-YFP, is described in Bierne et al. (2009). Antibodies used
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in the study were raised against BAHD1 (Abcam, 46573) and
HDAC1 (Abcam, ab7028). Preparation of chromatin extracts is
described in Lebreton et al. (2011). Immunofluorescence and
XIST FISH assays were carried out as described in Bierne et al.
(2009).
BS-seq Procedures
Isolated DNA was truncated into 100–300 bp fragments by
sonication followed by DNA-end repair, 3′-dA overhang addition
and ligation of methylated sequencing adapters. Samples
underwent bisulfite treatment with the ZYMO EZ DNA
Methylation-Gold kit. Desalted, size-selected, PCR amplified
fragments were size-selected again. Quality controlled libraries
were selected for Illumina sequencing by the Beijing Genomics
Institute (BGI). Data filtering included removing adaptor
sequences, contamination and low-quality reads from raw reads.
These reads were filtered by custom BGI scripts, as described
in Li et al. (2010). There were two types of low-quality reads
removed from the data: (1) when the ratio of N in whole read was
over 10%; (2) when the ratio of base whose quality was <20 was
over 10%. Observed cytosines on the forward read of each read
pair were in silico replaced by thymines, and observed guanines
on the reverse read of each read pair were in silico replaced
by adenines (Xiang et al., 2010). The “alignment form” reads
were then mapped to the “alignment form” reference genome by
SOAP aligner. Every hit with a single placement with minimum
numbers of mismatches and a clear strand assignment was
defined as unambiguous alignment (uniquely mapped reads) and
was used for methyl-cytosine determination. Only the uniquely
mapped reads were used to estimate the copy numbers of the
local region (Xiang et al., 2010). Genomic bases with a copy
number larger than 1.5 were not used to call methylcytosines
and not used in any subsequent analysis to avoid errors caused
by misalignment following the protocol described in Li et al.
(2010). For each of the replicates, 1.03 billion (HEK-CT) and
1.05 billion (HEK-BAHD1) paired-end reads of 90 bp length
were generated and aligned to the female human reference
sequence (NCBI build 37/hg19), yielding 93.0 and 94.3 gigabases
(Gb), with an average of 23.4 and 26.1-fold genome coverage.
In total, ∼38 and ∼37 million methylcytosines were detected
in HEK-CT and HEK-BAHD1, respectively, where >95% of
the queried CpGs had at least one read, and ∼85% had
more than four reads. Methylcytosines amounted for 3.35 and
3.45% of the cytosines with sequence coverage and ∼97% of
them were in the CpG context. Rare non-CpG methylation
(CHH and CHG) was present throughout all chromosomes
(Supplementary Figure S1). Whole-genome BS-seq reads were
subjected to data import, smoothing, and DMR analysis with
the Bioconductor package bsseq (Hansen et al., 2012). Replicates
were tiled over 300 bp windows for statistical analysis where
Fisher’s exact test was applied for inference with multiple-
testing adjusted values (Benjamini-Hochberg procedure, p <
0.1). DMRs were defined by subsetting the results based on a
regional methylation difference of at least 25% across the 300 bp
windows. To investigate a higher order organization, BAHD1-
specific DMRs were first counted and grouped over windows of
0.5Mb, defining “BAHD1-DMR clusters.” Then, the mapping of
DMR-rich regions was refined by defining contiguous domains
of DMR clusters with more than the 75% quantile of DMR
counts (i.e., representing the top 25% quantile). These domains
were referred to as “BAHD1-Associated differentially methylated
Domains” (BADs). The overlap between BADs and LADs was
calculated in the R environment using the data from Guelen et al.
(2008) accessible via the UCSC genome browser. Full datasets
have been deposited in Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo) and are accessible through GEO
series accession number GSE51867.
Native ChIP-seq Procedures
The immunoprecipitation of the HPC-BAHD1 protein in HPT-
BAHD1 cells with anti-Protein C antibodies is described in
Lebreton et al. (2011). A native ChIP (NChIP) of isogenic
HPT-HEK293 control cells was performed in parallel. 200µL of
eluted fractions from the first HPC4 affinity column, or 10µL
of input chromatin fractions diluted in 200µL, were used for
DNA extraction from two independent biological HPT-BAHD1
replicates or one HPT-HEK293 sample. DNAwas purified by two
extractions with 200µL of phenol:chloroform:isoamylalcohol
(25:24:1, pH = 8). Residual phenol was eliminated from the
aqueous phase by extraction with chloroform, after which DNA
was precipitated by addition of 900µL of ethanol, 100µL of
ammonium acetate 7.5M, and 0.2µL of glycogen (20µg/µL),
incubation at −80◦C for 30min and centrifugation at 4◦C,
20,000 × g for 15min. The pellet was washed once in 100µL
of ethanol, then suspended in 50µL of pure water for inputs
samples, while 25µL was used for NChIP samples.
For high-throughput sequencing, libraries were constructed
by Fasteris SA (Geneva, Switzerland) from Input and NChIP
samples, according to the Illumina guidelines. Independent
libraries were produced for two biological replicates of the
experiment, R1 and R2, input and control NChIP. The DNA
colony template library was sequenced as single reads of 50
bp. Sequencing was multiplexed at three libraries per channel.
We acquired a minimum of ∼37 million aligned unique reads
for HPT-BAHD1 and HPT-HEK293 NChIP and inputs, and
used stringent cut-offs for peak calling and statistical analysis
of replicate DNAs. Trimmed fastq files were mapped with
Bowtie version 0.12.7 to the female human genome (UCSC
hg19). Only uniquely mapping reads were used for further
analysis; clonal reads were removed. Initial peak calling was
performed with CCAT version 3.0 (Xu et al., 2010) with the
following parameters: fragmentSize = 150, slidingWinSize =
500, movingStep= 50, isStrandSensitiveMode= 0, minCount=
4, outputNum = 10000, randomSeed = 123456, minScore =
5.0, bootstrapPass = 50. A minimum of five-fold change of
NChIP over input was required for peak calling. Further analysis
was performed on the regions identified by CCAT with edgeR
(Robinson et al., 2010), by binning the genome into 200 and
400 bp non-overlapping windows. Reads were extended of 200 bp
to reflect the original size of the fragment. Empty windows
and outliers (>400 counts per bin) were excluded from the
analysis. edgeR analysis was performed with a generalized linear
model, excluding the effect of input and HPT-HEK293 control
NChIP from the model. Full datasets have been deposited in the
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Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/
geo) and are accessible through GEO series accession number
GSE53372.
Data Annotation
In order to investigate qualitative differences between samples,
data were subset for regions corresponding to genomic features
of interest. Annotations from Ensembl (version 72) were
retrieved using the interface biomaRt, which accesses ensembl
via BioMart, a federated system of databases. Annotation was
performed using custom scripts and functions built in the
IRanges, GenomicFeatures and ChIPpeakAnno. The UCSC CpG
island track was imported into the R environment using the
package rtracklayer. CpG island shores were defined as those
regions up to 2000 bp upstream and downstream of CpG islands.
The annotation for the human genome repeat regions was
downloaded from the repeat masker website hosted at the
Institute for Systems Biology (http://www.repeatmasker.org/cgi-
bin/AnnotationRequest). The lncRNA annotation (UCSC track:
lincRNAsTranscripts) was obtained from Cabili et al. (2011).
Gene Expression Microarrays
RNA quality was monitored using Agilent RNA Pico LabChips
(Agilent Technologies, Palo Alto, CA). One hundred nanogram
of RNA from HEK-CT or HEK-BAHD1 cells, was used
as templates for the synthesis of hybridization probes for
Affymetrix GeneChip Microarrays (Genechip HuGene 1.0 ST).
Hybridization was carried out with three biological replicates
according to the expression analysis technical manual with wash
and stain kit (Affymetrix). Gene-level expression values were
derived from the CEL file probe-level hybridization intensities
using the model-based Robust Multichip Average algorithm
(RMA; Bolstad et al., 2003). RMA performs normalization,
background correction and data summarization. An analysis was
performed using the LPE test (Jain et al., 2003) and a p-value
threshold of p < 0.05 was used as the criterion for expression.
The estimated false discovery rate (FDR) of this analysis was
calculated using the Benjamini-Hochberg (BH) procedure in
order to correct for multiple comparisons. Results were further
subset on absolute median difference >0.2. All data is MIAME
compliant and the raw data have been uploaded to the Gene
Expression Omnibus database (GEO series accession number
GSE51868).
RNA Extraction, Reverse Transcription,
and Quantitative PCR (RT-QPCR)
Total RNA from HEK-CT and HEK-BAHD1 cells was extracted
using the RNeasy Mini Kit (Qiagen), from three biological
replicates. Genomic DNA was removed by treatment with
TURBO DNA-freeTM kit (Ambion). cDNAs were generated
from 1 to 2µg total RNA using the RT2-HT first strand
kit (Qiagen/SABiosciences). Quantitative PCR was performed
on Bio-Rad MyIQ or cfx384 devices (Biorad), using SsoFast
Evagreen supermix (Biorad), as specified by the supplier, using
described BAHD1, IGF2, and GAPDH primers (Bierne et al.,
2009). Each reaction was performed in triplicate. Data were
analyzed by the11Ct method. Target gene expression data were
normalized to the relative expression of the GAPDH reference
gene.
RESULTS
Generation of a Human Cell Line Stably
Producing BAHD1
In order to investigate the effect of BAHD1 overexpression on
the dynamics of DNA methylation, we generated a HEK293
cell line with stable expression of BAHD1 (referred to as HEK-
BAHD1) by integration of a single copy of the BAHD1 coding
sequence under the control of the human cytomegalovirus
(CMV) promoter in the HEK293 genome. We also produced an
isogenic control line (referred to as HEK-CT), by integration of
the empty vector. The increase in BAHD1 mRNA levels by ∼60
fold in HEK-BAHD1 cells (Figure 1A) enabled the detection
of the BAHD1 protein in HEK-BAHD1 cells, in chromatin
extracts (Figure 1B), as well as in nuclei by immunofluorescence
microscopy, using BAHD1 antibodies (Figure 1C). In contrast,
endogenous BAHD1 was undetectable in control HEK-CT
chromatin (Figure 1B), consistent with the low expression of
BAHD1 in HEK293 cells and many other cell lines (Bierne
et al., 2009). We have previously shown that BAHD1 represses
expression of the IGF2 gene in HEK293 cells transiently
expressing BAHD1 from a plasmid (Bierne et al., 2009). In
agreement with these data, IGF2 mRNA levels decreased by
6 fold in HEK-BAHD1 cells, when compared to control cells
(Figure 1A). HEK293 are female cells with an atypical karyotype,
with often two copies of the inactive X chromosome (Xi). The two
Xi are visible as large heterochromatic bodies (Gilbert et al., 2000)
to which BAHD1 is recruited (Bierne et al., 2009). Accordingly,
we observed that BAHD1 was enriched at the Xi in HEK-
BAHD1 cells, as shown by labeling of BAHD1 and XIST RNA
(Figure 1D). The BAHD1 staining was less intense in HEK-
BAHD1 cells than in cells transiently transfected with an YFP-
BAHD1-expressing plasmid (Figure 1C). Thus, HEK-BAHD1
cells stably expressing BAHD1 can be used as a model system
to study whether increasing BAHD1 cellular levels affect DNA
methylation.
BAHD1 Overexpression Differentially
Changes the DNA Methylation Landscape
of Autosomes and chrX
In order to obtain high-resolution DNA methylation profiling,
we performed whole-genome BS-seq (MethylC-seq/BS-seq Lister
et al., 2009) of two HEK-BAHD1 replicates and of the HEK-
CT control DNA, generating complete reference methylomes
of these cell lines at single base resolution (see Materials
and Methods and Supplementary Figure S1A for detailed
analytical procedures). We verified that our BS-seq results were
in agreement with partial methylomes previously released for
HEK293 cells in ENCODE RRBS and HEK293 chromosome 21
datasets (Zhang et al., 2009; ENCODE Project Consortium, 2012;
Supplementary Figure S2). Comparison of these methylomes
highlighted a significant gain of methylation (on average ∼2 ±
0.66%) in autosomes of HEK-BAHD1 cells, when compared
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FIGURE 1 | Constitutive expression of BAHD1 in HEK-BAHD1 cells.
(A) RT-QPCR measurement of BAHD1 and IGF2 mRNA levels in HEK-BAHD1
relative to that in HEK-CT. Bars represent mean±SD of three replicates.
(B) Immunoblot of chromatin extracts from HEK-CT and HEK-BAHD1 with
BAHD1 or HDAC1 antibodies. Endogenous BAHD1 is undetectable in the
control line. (C) Immunofluorescence studies of BAHD1 location in HEK-CT,
HEK-BAHD1, or in HEK293 cells transfected with a plasmid expressing
BAHD1-YFP. Scale bars, 5µm. BAHD1 localizes to Xi in cells overexpressing
BAHD1 from a chromosomal integration or from a plasmid (arrows). (D)
Overlay image of an immunoFISH assay with anti-BAHD1 antibodies (green),
combined with Xist RNA FISH (red), and staining of nuclei with DAPI (blue).
to autosomes of HEK-CT cells, corresponding to methylation
of ∼478,000 CpG. In contrast, the average methylation level
on chrX decreased by ∼4 ± 0.05% (Figure 2A; Table 1).
Differential analysis of HEK-CT and HEK-BAHD1 methylome
replicates (Fisher’s exact test, p < 0.1, BH-corrected, minimum
methylation difference 25%) identified 91,358 regions of 300 bp
that became reproducibly differentially methylated in the two
biological replicates of the HEK-BAHD1 DNA, when compared
to the isogenic control. 83,850 of these differentially methylated
regions (herein referred to as “BAHD1-DMRs”) mapped on
autosomes and 7508 on chrX (Figure 2B; Table 2). Relative to
chromosome size, the highest enrichment of BAHD1-DMRs
was on chrX (Figure 2C; Table 2). In agreement with global
methylation levels, 89.5% of BAHD1-specific DMRs identified
on autosomes showed a gain of methylation (referred to as
“hyper-DMRs”), whereas 81.8% DMRs on chrX showed a loss
of methylation (“hypo-DMRs”). These results indicate that up-
regulation of BAHD1 induces de novo cytosine methylation on
autosomes and loss of methylation on chrX.
Distribution of BAHD1-specific DMRs on
Autosomes
We next examined the location of BAHD1-DMRs in different
genomic elements on autosomes. The majority of DMRs were
principally outside of CpG islands and mapped on intergenic
regions, introns and interspersed repeats (LINEs, LTR, SINEs;
Figure 2D). Relative to the size of each genomic element, hyper-
DMRs were particularly enriched at satellites and other repeat
sequences, intergenic regions and lncRNAs, whereas they rarely
mapped in 5′UTRs, CGIs, and promoters (Figure 2E; Table 3A).
Subsets of hypermethylated BAHD1-DMRs were observed at
enhancers (4579) and CGI-shores (1175), which like CGIs, are
cis-regulatory modules that play important role in regulation
of gene expression (Schilling and Rehli, 2007; Irizarry et al.,
2009). The % of mCpG can be divided into low levels (0–25%),
“partiallymethylated domains” (PMD) and high levels (75–100%;
Lister et al., 2009; Hon et al., 2012). The directional change
in methylation in response to overexpression of BAHD1 went
toward a higher methylation (Table 4A).
We searched for the presence of binding sites for BAHD1-
associated partners in hypermethylated BAHD1-DMRs on
autosomes by examining the overlap of DMRs and binding
sites for transcription regulators listed in the ENCODE
TFBS (Transcription Factor Binding Sites) cluster track.
Remarkably, the two first transcription regulators of this analysis
(Supplementary Table S1) were SETDB1 and KAP1, two known
partners of BAHD1. HP1-γ, HDAC2 and the transcription factor
SP1, which also co-precipitate with BAHD1 in HEK293 cells
(Bierne et al., 2009; Lebreton et al., 2011) were also in this list.
Additionally, there were binding sites for EZH2, the H3K27
KMT that induces H3K27me3, a mark associated with BAHD1
heterochromatic foci (Bierne et al., 2009), and STAT transcription
factors (STAT1, STAT3, and STAT5A) that can be functionally
related to BAHD1-mediated repression of interferon-stimulated
genes (Lebreton et al., 2011). These findings support the
hypothesis that BAHD1, in association with its partners within
macromolecular complexes, is mechanistically linked to the
establishment of DNA methylation patterns on autosomes.
Distribution of BAHD1-specific DMRs on
chrX
In contrast to what was observed on autosomes, comparison
of methylation profiles on chrX in HEK-CT and HEK-
BAHD1 DNA revealed a puzzling loss of methylation on all
genomic elements, from the high level to partially methylated
level (Table 4B), with the exception of satellites that gained
methylation like in autosomes. DMR analysis emphasized
unique patterns of differential methylation on chrX in BAHD1-
overexpressing cells. Relative to the size of each genomic element,
DMR counts at enhancers, gene bodies (3′-UTR, introns, exons)
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FIGURE 2 | BAHD1-induced differential methylation among chromosomes and genomic elements. (A) Global difference in the percentage of CpG
methylation level between HEK-CT and HEK-BAHD1 DNA in autosomes and chrX (methylation level = 100 * total mC reads/all reads). Results are mean±SD of two
(Continued)
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FIGURE 2 | Continued
biological replicates. (B) Number of BAHD1-specific DMRs in autosomes and chrX of HEK-BAHD1 cells relative to that in HEK-CT cells. Hypermethylated DMRs: red.
Hypomethylated DMRs: blue. (C) Enrichment of BAHD1-DMRs relative to autosome size; chrX is shown apart. (D) Number of BAHD1-DMRs in genomic elements.
(E,F) Relative enrichment in genomic elements of BAHD1-hyper-DMRs on autosomes (E) or BAHD1-hypo-DMRs on chrX (F). The proportion of DMRs was
normalized by the length and abundance of the queried element in the genome. Regions significantly over-represented in differentially methylated regions are indicated
(***p < 0.001). (G,H) Number of BAHD1-specific peaks in HPT-BAHD1 NChIP replicates in chromosomes (G) or genomic elements (H).
TABLE 1 | Average percentage of methyl-cytosines per chromosome in
HEK-CT and HEK-BAHD1 cells.
Chromosome HEK-CT HEK-BAHD1 HEK-BAHD1
Replicate1 Replicate2 Mean sd
chr1 70.09 72.06 72.47 72.27 0.29
chr2 67.45 69.2 70.32 69.76 0.79
chr3 67.34 69.01 69.75 69.38 0.52
chr4 59.67 61.31 61.68 61.5 0.26
chr5 61.81 61.66 61.48 61.57 0.13
chr6 68.21 70.46 71.4 70.93 0.66
chr7 67.21 69.13 70.23 69.68 0.78
chr8 60.9 63.21 63.85 63.53 0.45
chr9 71.45 73.1 74.42 73.76 0.93
chr10 65.97 67.84 67.33 67.59 0.36
chr11 66.45 68.06 68.92 68.49 0.61
chr12 66.03 68 68.88 68.44 0.62
chr13 63.38 65.22 65.63 65.43 0.29
chr14 67.08 68.29 69.75 69.02 1.03
chr15 71.58 73.15 74.24 73.7 0.77
chr16 57.3 57.39 60.03 58.71 1.87
chr17 75.16 76.47 77.8 77.14 0.94
chr18 63.89 65.24 66.41 65.83 0.83
chr19 70.6 71.93 73.17 72.55 0.88
chr20 71.71 73.71 75.27 74.49 1.1
chr21 63.06 67.94 67.97 67.96 0.02
chr22 76.1 77.47 79.45 78.46 1.4
Mean autosomes 66.93 68.63 69.57 69.1 0.66
chrX 42.91 38.97 38.9 38.94 0.05
Bold values highlight methylation level in each chromosome in HEK-CT (one BS-seq) and
HEK-BAHD1 (mean of two independent BS-seq). These data have been processed as
described in Li et al. (2010).
and SINEs showed the highest pattern of hypomethylation on
chrX (Figure 2F). There were only 4 BAHD1-DMRs on CGIs
(all hypo-methylated) and no DMRs on 5′-UTR and promoters
(Table 3B). Thus, in contrast to autosomes, most BAHD1-DMRs
on chrX are enriched in enhancers and gene bodies and are hypo-
methylated in comparison with the same regions in control cells.
Relationship Between BAHD1-associated
Differential DNA Methylation and Gene
Expression
With the aim of investigating the potential association
between BAHD1-induced DNA methylation changes and
gene expression, we generated transcriptome datasets of HEK-
CT and HEK-BAHD1 lines, using Affymetrix DNA arrays.
Analysis of differential gene expression between the two lines
yielded 1304 up-regulated and 1137 down-regulated transcripts
upon BAHD1 overexpression (LPE, BH-adjusted p < 0.05).
Given the role of BAHD1 in transcriptional repression, our
analysis principally focused on genes that were down-regulated
in HEK-BAHD1 cells. We found BAHD1-specific DMRs in 701
(61%) repressed genes, within a window encompassing 10 kb
upstream to 10 kb downstream of each gene. In most autosomes,
there was a significantly higher proportion of hyper-DMRs
than hypo-DMRs associated with repressed genes (Figure 3),
suggesting that BAHD1-associated de novo DNAmethylation on
autosomes is mainly associated with gene repression.
On chrX, analysis of the transcriptome datasets identified
119 genes that were differentially expressed in HEK-BAHD1
when compared to HEK-CT cells, of which 72 (60%) were
down-regulated. In contrast to autosomes, the majority of chrX
genes that were repressed in HEK-BAHD1 cells were associated
with hypomethylated DMRs in both BS-seq replicates (i.e.,
58/72; Supplementary Table S2; Figure 3). Since BAHD1 targets
the Xi (Figure 1), we searched for evidence linking BAHD1-
associated repression to known methylation changes on the Xi.
As mentioned above, there was no BAHD1-specific hyper-DMR
on CGIs of chrX (Table 3B), ruling out an effect of BAHD1
in CGI methylation on the Xi. We investigated whether chrX
genes that were down-regulated in HEK-BAHD1 were known
to be always inactivated on Xi, or could escape X inactivation,
by using published data on the status of Xi genes (Zhang
et al., 2013). Thirty-two repressed genes were present in this
list, of which 13 were classified as “always inactive” and 19 as
“heterogeneous” (Supplementary Table S2). Taken together, these
results suggest that repression of a set of chrX genes in HEK293
cells overexpressing BAHD1 might be due to loss of methylation
on Xi, opening the possibility that BAHD1 might be involved in
heterogeneous repression on Xi-linked genes.
BAHD1-specific DMRs are Clustered into
Large Chromosomal Domains
We previously noticed that high-level overexpression of BAHD1
from a plasmid in HEK293 cells triggers massive compaction
of chromatin visible when observed in electron microscopy
(Bierne et al., 2009). We hypothesized that BAHD1-mediated
heterochromatinization might spread and that this event might
coincide with BAHD1-associated DNA methylation changes on
large regions. To address this hypothesis, the overall genomic
distribution of BAHD1-DMRs was examined at a higher scale
by binning DMRs into 0.5Mb windows (i.e., “BAHD1-DMR
clusters”). This analysis revealed that BAHD1-DMRs were
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TABLE 2 | Numbers of BAHD1-specific DMRs per chromosome.
chr Total DMRs Hyper-DMRs % Hyper-DMRs Hypo-DMRs % Hypo-DMRs Chromosome Nb. of DMRs relative
length (bp) to chromosome length
chrX 7508 1368 18.2 6140 81.8 1.55E+08 4.84E-05
chr6 6447 5871 91.1 576 8.9 1.71E+08 3.77E-05
chr5 6587 5877 89.2 710 10.8 1.81E+08 3.64E-05
chr20 2232 2055 92.1 177 7.9 6.30E+07 3.54E-05
chr1 8676 8128 93.7 548 6.3 2.49E+08 3.48E-05
chr2 8373 7106 84.9 1267 15.1 2.43E+08 3.44E-05
chr3 6649 5902 88.8 747 11.2 1.98E+08 3.36E-05
chr10 4333 3979 91.8 354 8.2 1.36E+08 3.20E-05
chr12 4263 3988 93.5 275 6.5 1.34E+08 3.19E-05
chr7 4987 4576 91.8 411 8.2 1.59E+08 3.13E-05
chr8 4316 3783 87.7 533 12.3 1.46E+08 2.95E-05
chr17 2288 2014 88 274 12 8.12E+07 2.82E-05
chr11 3638 3157 86.8 481 13.2 1.35E+08 2.70E-05
chr19 1515 1414 93.3 101 6.7 5.91E+07 2.56E-05
chr4 4845 4287 88.5 558 11.5 1.91E+08 2.54E-05
chr21 1152 942 81.8 210 18.2 4.81E+07 2.39E-05
chr9 3259 2907 89.2 352 10.8 1.41E+08 2.31E-05
chr16 2019 1865 92.4 154 7.6 9.04E+07 2.24E-05
chr14 2121 1803 85 318 15 1.07E+08 1.98E-05
chr18 1514 1301 85.9 213 14.1 7.81E+07 1.94E-05
chr13 2151 1929 89.7 222 10.3 1.15E+08 1.87E-05
chr15 1807 1559 86.3 248 13.7 1.03E+08 1.76E-05
chr22 678 613 90.4 65 9.6 5.13E+07 1.32E-05
Total autosomes 83850 75056 89.51 8794 10.49
This table includes counts for non-overlapping 300 bps windows, which have been found differentially methylated in HEK-BAHD1, when compared to HEK-CT BS-seq, and which localize
to individual chromosomes. DMRs are divided in hyper-methylated (more methylation than control: hyper-DMRs) and hypo-methylated (less methylation than control: hypo-DMRs). The
results are ranked according to the enrichment of DMRs relative to the chromosome size. Bold Letters highlight values in chrX and in all autosomes.
non-uniformly distributed along the whole human genome
(Figure 4). In order to refine the mapping of regions with high
density of DMRs, we defined contiguous domains in DMR
clusters where the DMR counts were in the top quartile of the
genome-wide DMR distribution. Examples of such “BAHD1–
Associated differentiallymethylatedDomains” (BADs) are shown
in Figure 5, for chr6 and chrX. Overall, we found 839 BADs with
sizes of 0.3–6.5Mb (median 0.5Mb), mostly hypermethylated in
autosomes (792 “hyper-BADs”) and hypomethylated in chrX (26
“hypo-BADs”).
Several genome-wide analyses have revealed diverse
chromatin domains that play important roles in nuclear
organization and function (Hu et al., 2012; Padeken and Heun,
2014). Of these, Lamina-Associated Domains (LADs) are
proposed to be dynamic heterochromatic structures located
to the nuclear periphery and correlated with gene repression
(Guelen et al., 2008; Luperchio et al., 2014). Interestingly,
in autosomes, 60% of hyper-BADs overlapped with LADs
(p < 0.001, hyperG test). These results highlight the possibility
that BAHD1-induced DNA methylation is linked to de
novo formation of heterochromatic domains at the nuclear
periphery. In addition, we noticed that in agreement with the
hypermethylation of satellites found in our pattern analyses
(Figure 2; Table 3), a set of hyper-BADs, including those located
on chrX, mapped to pericentromeric regions (Figure 5), which
are known regions of constitutive heterochromatin. Thus,
BAHD1-associated chromatin repressive complexes might play
a role in heterochromatinization of pericentromeric satellites by
increasing their 5 mC content. The repartition of hypo-BADs on
chrX was also non-random. Hypo-BADs particularly mapped
in enhancers and gene bodies (introns, exons) and were more
abundant on the short arm of chrX (Xp) than on the long
arm (Xq), and absent from the central region, in particular
on the proximal part of Xq (Figure 5). Overall, these results
suggest that overexpression of BAHD1 may dynamically alter
heterochromatin topology by formation of large differentially
methylated domains with distinct consequences on chrX and
autosomes.
Mapping of BAHD1-occupancy Domains in
Response to BAHD1 Overexpression
We next aimed to find out whether overexpression of BAHD1
stimulates binding of BAHD1 on large chromatin domains.
So far, our efforts to immunoprecipitate the endogenous
BAHD1 protein using different commercial or custom antibodies
has been unsuccessful. To map the genome-wide distribution
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TABLE 3 | Number and relative enrichment of BAHD1-specific DMRs in genomic elements in autosomes and X chromosome.
Genomic Hyper-DMRs % Hyper-DMRs on Enrichment Genomic Hypo-DMRs % Hypo-DMRs on Enrichment
elements autosomes all autosomal DMRs elements autosomes all autosomal DMRs
A. AUTOSOMES
Satellites 1446 99.1 14.9 LTR 1151 9.1 0.5
LTR 11560 90.9 5.1 Enhancers 1005 18 0.4
Intergenic 51242 91 4.1 Repeats 4397 9.7 0.4
Repeats 40871 90.3 3.4 Intergenic 5086 9 0.4
lncRNA 4935 90.3 2.9 CGI 72 55.4 0.3
Introns 23132 86.6 2.1 Shores 299 20.3 0.3
Sines 6920 88.4 1.8 3′-UTR 78 18.8 0.3
Enhancers 4579 82 1.8 Exons 285 14.8 0.3
Lines 17105 90.2 1.5 Introns 3568 13.4 0.3
Exons 1646 85.2 1.5 lncRNA 529 9.7 0.3
3′-UTR 337 81.2 1.2 Sines 904 11.6 0.2
Shores 1175 79.7 1.2 Lines 1848 9.8 0.2
5′-UTR 34 79.1 0.5 5′-UTR 9 20.9 0.1
CGI 58 44.6 0.3 Satellites 13 0.9 0.1
Promoters 76 89.4 0.2 Promoters 9 10.6 0
Genomic Hyper-DMRs % Hyper-DMRs on Enrichment Genomic Hypo-DMRs % Hypo-DMRs on Enrichment
elements chrX all chrX DMRs elements chrX all chrX DMRs
B. X CHROMOSOME
Satellites 280 100 38.7 Enhancers 1179 91.5 10.9
Shores 39 22 1.3 3′-UTR 87 89.7 8.5
Intergenic 970 26.9 1.2 Introns 3284 89.9 7.8
Repeats 942 22.8 1.2 Sines 1024 88.8 6.7
3′-UTR 10 10.3 1 Exons 248 89.9 6.3
Enhancers 109 8.5 1 Shores 138 78 4.6
LTR 141 17.3 0.9 LTR 672 82.7 4.5
Introns 367 10.1 0.9 Repeats 3193 77.2 4.1
Lines 318 22.1 0.8 lncRNA 191 88 3.4
Sines 129 11.2 0.8 Intergenic 2634 73.1 3.1
Exons 28 10.1 0.7 Lines 1123 77.9 2.7
lncRNA 26 12 0.5 CGI 4 100 0.6
5′-UTR 0 0 0 5′-UTR 0 0 0
CGI 0 0 0 Promoters 0 0 0
Promoters 0 0 0 Satellites 0 0 0
This table includes counts for non-overlapping 300 bps windows, which have been found differentially methylated in HEK-BAHD1, when compared to HEK-CT BS-seq, and which
localize to individual genomic elements. DMRs are divided in hyper-methylated (more methylation than control, “hyper-DMRs”) and hypo-methylated (less methylation than control,
“hypo-DMRs”). The results are ranked according to the enrichment relative to the size of each genomic feature, as highlighted in bold.
of BAHD1 binding sites in response to transient induction
of BAHD1 expression, we used a HEK293 cell line stably
expressing tetracycline-inducible His6-Protein C (HPC)-tagged
BAHD1 (referred to as HPT-BAHD1 cells) that we generated
earlier (Lebreton et al., 2011). The genomic DNA present
in chromatin extracts from HPT-BAHD1 cells before (input)
and after immunoprecipitation (ChIP) of the HPC-BAHD1
protein with Protein C antibodies was analyzed by high-
throughput sequencing. This Native ChIP-seq (NChIP-seq)
enabled the analysis of the DNA to which BAHD1 binds
without any requirement for formaldehyde crosslinking. To
filter out non-specific DNA binding on the affinity matrix, we
also performed NChIP-seq analysis of HPT-HEK293 control
chromatin extracts. A stringent analysis yielded 4936 and 5742
BAHD1-binding events (“BAHD1-peaks”) across the genome
in replicates 1 and 2, respectively. Notably, the distribution
of BAHD1-peaks across chromosomes showed enrichment of
BAHD1 binding sites on chrX, with 24% (replicate 1) and 21%
(replicate 2) of all BAHD1-peaks mapping on this chromosome
(Figure 2G). This result is in agreement with enrichment of
BAHD1-DMRs on chrX and with the recruitment of BAHD1
to the Xi. Regarding the distribution on genomic elements, 80%
of BAHD1-peaks preferentially mapped at interspersed repeats
LINEs and SINEs (37.4± 5.9%), intergenic regions (33.2± 0.1%),
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TABLE 4 | Average difference in global methylation levels per genomic
elements between HEK-CT and HEK-BAHD1 cells.
Average Difference between
HEK-BAHD1 and HEK-CT
Low (0–25%) PMD (25–75%) High (75–100%)
A. AUTOSOMES
Satellite −6.1 −1.52 7.61
LTR −1.85 −4.21 6.06
Intergenic −1.6 −4.25 5.85
lncRNA −1.47 −4.35 5.82
Lines −2.07 −3.18 5.24
Enhancers −0.13 −3.26 3.38
Introns −0.43 −2.88 3.29
Sines −0.61 −2.41 3.01
Shores 0.04 −2.6 2.54
Exons 0.25 −2.02 1.78
Promoters 0.27 −1.9 1.62
3′-UTR −0.1 −0.62 0.7
CGI 0.53 −1.06 0.52
5′-UTR 0.68 −0.94 0.25
B. chrX
Satellite −9.46 −10.96 20.68
LTR 0.47 5.31 −5.8
Intergenic 0.2 4.54 −4.76
lncRNA 2.85 4.24 −7.09
Lines 0.31 2.79 −3.11
Enhancers −1.11 15.11 −14.01
Introns 0.51 11.9 −12.41
Sines 0.34 12.09 −12.43
Shores −4.94 14.8 −9.86
Exons −2.59 12.54 −9.96
Promoters −7.27 13.69 −6.43
3′-UTR 1.15 13.42 −14.57
CGI −10.41 12.21 −1.81
5′-UTR −10.71 12.93 −2.22
The methylation level ranges were defined into low levels (0–25%), partially methylated
domains (25–75%), and high levels (>75%). The average difference indicates subtraction
of HEK-BAHD1 (replicates 1 and 2) from HEK-CT methylation levels, with positive and
negative differences in red and blue boxes, respectively.
and introns (13.6 ± 3.4%; Figure 2G). Relative to the size of
each genomic element, BAHD1-peaks were, like BAHD1-DMRs,
mostly enriched at satellites (Table 5).
Binning BAHD1-specific peaks into 0.5Mb windows revealed
that they clustered into larger regions, as BAHD1-DMRs.
Examples of such “BAHD1–occupancy domains” are shown for
chr6, chr7, and chrX on Figure 6A. Surprisingly, overlapping
BAHD1–occupancy and–differentially methylated regions
revealed a marked difference between autosomes and chrX. On
autosomes, BAHD1-binding and–hypermethylated domains
often overlapped or were adjacent. In contrast, on chrX, there was
an inverse correlation between the location of BAHD1-binding
and hypomethylated domains (Figure 6B). Furthermore,
BAHD1-occupancy domains were more abundant on the long
FIGURE 3 | Relationship between BAHD1-DMRs and gene expression.
Histograms represent, for each autosome and chrX, the number (“counts”) of
hypermethylated or hypomethylated DMRs that are located within a window of
10 kb upstream to 10 kb downstream of a gene differentially expressed
(activated or repressed) in HEK-BAHD1 cells compared to HEK-CT.
arm (Xq) than the short arm of chrX (Xp), particularly in the
half part of Xq containing the X-inactivation center (XIC)
on the Xi. Taken together, these data are in agreement with
the hypothesis that BAHD1 plays distinct roles on chrX and
autosomes and support a model in which BAHD1-mediated
chromatin compaction coincides with binding of BAHD1 on
large genomic regions.
DISCUSSION
In this study, we report that increasing BAHD1 cellular levels
in human embryonic 293 cells is sufficient to trigger profound
changes in CpG methylation patterns at both the local (kb)
and large (Mb) genome scale. In addition, BAHD1-associated
methylation signatures are distinct depending on location, with
gain of methylation on autosomes and loss of methylation
on chrX. We cannot exclude that these changes are indirect
consequences of BAHD1 expression at non-physiologically high
levels. Yet, our experimental data provide insight into potential
functions of BAHD1 in epigenetic regulation. We hypothesize
a role for BAHD1 in the modulation of DNA methylation
patterning and in the spatial organization of silent chromatin.
Our results indicate that BAHD1-specific hypermethylated
DMRs are enriched in binding sites for the known BAHD1-
associated partners SETDB1, KAP1, HP1-γ and HDAC2, as well
as for the H3K27me3 writer EZH2, which are all known to
interact with de novo DNMTs (Fuks et al., 2001, 2003; Lehnertz
et al., 2003; Li et al., 2006; Vire et al., 2006; Rush et al., 2009).
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FIGURE 4 | Distribution of BAHD1-DMR clusters across the genome. DMRs present in HEK-BAHD1 cells in comparison to HEK-CT cells were binned into 0.5
Mb windows as “BAHD1-DMR clusters” represented by bars. The distribution of clusters across the genome of HEK-BAHD1 cells, with hypermethylated clusters in
red and hypomethylated clusters in blue, is plotted with Circos (Krzywinski et al., 2009).
Also of interest is the presence in a subset of BAHD1-DMRs
of binding sites for the transcription factor SP1, with which
BAHD1 co-immunoprecipitates (Bierne et al., 2009), as well as
for STAT factors that may act in synergy with BAHD1 to repress
immunity gene expression during a bacterial infection (Lebreton
et al., 2011). In addition, the comparison of HEK293 and
HEK-BAHD1 transcriptomes suggests a relationship between
the location of BAHD1-DMRs and BAHD1-associated repressed
genes. It is worth mentioning that BAHD1 has similarities to
the metastasis-associated proteins (MTAs) of the Nucleosome
Remodeling and Deacetylation (NuRD) co-repressor complex
(Lai and Wade, 2011), which has been shown to couple histone
deacetylation and DNA methylation (Morey et al., 2008; Latos
et al., 2012). Like MTAs, BAHD1 is a BAH domain-containing
protein that binds a reader of 5-methylcytosines (i.e., MBD1,
Bierne et al., 2009). BAHD1 might thus act as a scaffold protein
that bridges MBD1 and HDAC1/2, as MTAs, and also connects
HP1 and KMTs, which can recruit DNMTs. These data converge
to a model in which BAHD1-associated multiprotein complexes
act in synergy with the DNA methylation machinery to form
repressive chromatin.
When transiently overexpressed from plasmid-based
expression systems, BAHD1 promotes the formation of nuclear
heterochromatic foci (Bierne et al., 2009). These foci seem to
correspond to different heterochromatin subtypes, as they are
enriched with HP1-α, a marker of constitutive heterochromatin,
or H3K27me3, a feature of facultative heterochromatin,
but HP1-α and H3K27me3 do not strictly overlap in these
foci (Bierne et al., 2009). BAHD1 is also recruited to Xi, a
paradigm of facultative heterochromatin. In addition, BAHD1
interacts with chromatin regulators that play a role in the
formation of both constitutive and facultative heterochromatin
(i.e., HP1 proteins α, β and γ, KAP1, HDAC1/2, SETDB1).
Here we show that stable expression of BAHD1 in HEK293
cells induces de novo DNA methylation at different genomic
elements in autosomes, predominantly at satellites, the major
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FIGURE 5 | BAHD1-specific domains (BADs). Large-scale genomic organization of DMRs present in HEK-BAHD1 cells in comparison to HEK-CT cells is
illustrated for an autosome (chr6) and for chrX. Scale indicates the number of DMRs per 0.5Mb window. Bars represent clusters of DMRs with gain of methylation
(hyper-DMRs, in red) or loss of methylation (hypo-DMRs, in blue). BADs (indicated by black boxes) correspond to contiguous domains of DMR clusters where DMR
counts are in the top quartile of the genome-wide DMR distribution. The position of genes is shown below. (A) Chromosome-wide representation of hypermethylation
and hypomethylation domains on chr6 (top) and chrX (bottom). Arrows indicate the position of pericentromeric regions. (B) Magnification of the domain squared in A,
with a chr6 hypermethylation domain (left) and a chrX hypomethylation domain (right). The position of DMRs in introns and enhancers is shown below.
component of the pericentromeric heterochromatin, and other
regions prone to being packaged into heterochromatin (i.e.,
interspersed repeats, intergenic regions, introns and sequences
transcribed in non-coding RNAs). BAHD1 overexpression also
increases DNA methylation at a set of cis-regulatory modules,
including enhancers and CGI shores. Several studies suggest
that methylation of these modules may play a more significant
role in the regulation of gene expression than CGIs (Irizarry
et al., 2009; Hon et al., 2013; Long et al., 2013; Ziller et al., 2013).
We hypothesize that BAHD1-associated chromatin repressive
complexes may recruit DNMTs to non-coding DNA repeats, thus
contributing to the stabilization of constitutive heterochromatin,
and/or to cis-regulatory modules, and thereby compacting
these key regulatory elements into facultative heterochromatic
domains leading to gene silencing. However, it is also possible
that upon BAHD1 overexpression, BAHD1-interacting proteins
are delocalized from various endogenous complexes, which
could indirectly alter the DNA methylome.
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TABLE 5 | Number and relative enrichment of BAHD1-specific peaks in genomic elements in HPT-BAHD1 NChIP-seq replicates.
Genomic element Nb. of BAHD1 peaks Nb. of BAHD1 peaks Replicate 1 Replicate 2 Mean
Replicate 1 Replicate 2 enrichment enrichment enrichment
Satellites 675 234 2.183 0.757 1.47
Lines 3940 3647 0.151 0.14 0.1455
Intergenic 3691 3859 0.087 0.09 0.0885
lncRNA 326 369 0.064 0.072 0.068
Enhancers 613 382 0.08 0.05 0.065
Introns 1240 1864 0.038 0.058 0.048
Sines 416 724 0.019 0.032 0.0255
LTR 131 391 0.011 0.034 0.0225
Promoters 11 24 0.009 0.02 0.0145
Exons 34 116 0.006 0.02 0.013
3′-UTR 4 20 0.004 0.018 0.011
Shores 13 31 0.004 0.011 0.0075
5′-UTR 1 5 0.002 0.011 0.0065
CGI 1 0 0.001 0 0.0005
Mean of enrichement in biological replicates is highlighted in bold.
NChIP-seq analysis of BAHD1-binding sites suggests that
BAHD1 spreads on chromatin in BAHD1-overexpressing cells
(Figure 6). This spreading might coincide with propagation of
DNA methylation, as we identified regions with high densities
of BAHD1-DMRs. Indeed, BAHD1-DMRs are non-uniformly
distributed along the genome and group into large chromosomal
domains, termed BADs. We find that 60% of BADs coincide with
LADs, which are large genomic segments anchored at the nuclear
periphery. LADs are proposed to be nuclear compartments of
silent chromatin formed in response to development stimuli
(Guelen et al., 2008; Luperchio et al., 2014; Padeken and
Heun, 2014). The size distribution (0.1–10Mb) and the median
sequence length (0.5–0.8Mb) of LADs are very similar to that of
BADs (0.3–6.5Mb; median 0.5Mb). Furthermore, our previous
electron microscopy experiments highlighted BAHD1-induced
heterochromatin at the nuclear periphery (Bierne et al., 2009).
From this, we propose that BAHD1 may mediate chromatin
reorganization into de novo heterochromatic regions through
DNA methylation changes, thereby contributing to the three-
dimensional organization of chromatin within the nucleus,
in response to developmental, physiological or environmental
stimuli. Interestingly, a recent study compiling data from a
100 human epigenomes highlights the dynamics of mCpG
distribution across tissue and cell types and emphasizes the
importance of examining this dynamics at the megabase-scale
(Roadmap Epigenomics et al., 2015). Taken together, these
results call for future research to investigate whether BADs are
formed in response to activation of the BAHD1 endogenous gene
by external stimuli. Such stimuli, and their effect on BAHD1
expression level in different tissues, are presently unknown.
It is therefore, necessary to characterize the cellular signaling
pathways that control BAHD1 expression and association with
other proteins.
In this work, we also show that in HEK293 female cells
overexpressing BAHD1, chrX undergoes a significant loss of
DNA methylation, while being a binding hotspot for BAHD1.
We cannot assign these methylation changes to specific Xi or Xa
territories because the data were derived from mixed cell and
chromosome populations. However, since BAHD1 is recruited
to Xi, as shown by microscopy, it is tempting to speculate that
overexpression of BAHD1 triggers a loss of DNA methylation on
the Xi. This observation must be put into perspective within the
specific context of the differential methylation of Xi compared
to Xa chromosomes in female cells. Different pieces of evidence
suggests that DNA methylation patterns are inverted on Xi and
Xa, with CGIs and gene bodies being more and less methylated,
respectively (Viegas-Pequignot et al., 1988; Prantera and Ferraro,
1990; Weber et al., 2005; Hellman and Chess, 2007). Up to now,
a mechanistic explanation of the role of gene body methylation
and gene silencing on Xi is still missing. We found that BAHD1-
specific DMRs on chrX are clustered into hypomethylated
domains on gene bodies, particularly on the short arm of chrX
(Xp), in contrast with BAHD1-occupancy domains, which are
abundant on the long arm (Xq). This puzzling observation opens
the possibility, among other hypotheses, that overexpressed
BAHD1 may sequester DNMTs at certain sites of Xq, altering
X-gene body methylation in cis on Xp. Interestingly, two recent
studies point to a possible role for BAHD1 at Xi: BAHD1
co-purifies with CDYL, a new partner of Xi (Escamilla-Del-
Arenal et al., 2013) and BAHD1 interactors MBD1 and SETDB1
were found to contribute to the maintenance of X inactivation
in somatic cells (Minkovsky et al., 2014). Overall, this work
establishes a basis for future studies aimed at exploring the role
of BAHD1 in transcription/maintenance/stability of the Xi.
CONCLUSIONS
De novo changes in DNA methylation patterns induced by
the stable overexpression of BAHD1 in HEK293 cells suggest
that BAHD1 may play a role in the formation of distinct
types of heterochromatic domains by controlling the setting
and distribution of mCpG. We did not demonstrate that the
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FIGURE 6 | BAHD1-specific binding domains. (A) Large-scale genomic organization of BAHD1-binding sites (“occupancy domains”) upon induction of BAHD1
expression for 30 h in HPT-BAHD1 cells. Sequencing DNA from NChIP of Protein-C-tagged BAHD1 generated peaks that were clustered in 0.5Mb windows (black
bars). Results are shown for two autosomes (chr6, chr7) and chrX. Scale indicates the number of peaks per bar. (B) Overlap of BAHD1-DMR clusters and
BAHD1-occupancy domains on chr6 (hypermethylated DMRs) and chrX (hypomethylated DMRs). The position of XIC and genes is indicated.
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DNA methylation changes observed in this study are a direct
consequence of BAHD1 binding to the chromatin. To confirm
these hypotheses, it is now essential to study whether the DNA
methylome is remodeled upon inactivation of the endogenous
BAHD1 gene. The use of novel techniques to generate knockout
cells or animals, such as the CRISPR/Cas9 technology, should
facilitate the achievement of these goals, opening an exciting new
area of future research on this epigenetic regulator.
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